Abbott (NYSE:ABT) announced that it made its Lingo continuous glucose monitoring (CGM) system available for purchase on ...

Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...

A study highlighted the accuracy of three leading continuous glucose monitors (CGM), including systems from Abbott and Dexcom.

For 2025, Insulet expects revenue growth between 16% and 20%. It projects Omnipod sales to increase by 17%-21%.

Blue Cross Blue Shield of Massachusetts announced that it expanded its care options for members with diabetes.